Salivary Duct Carcinoma in Parotid Deep Lobe, Involving the Buccal Branch of Facial Nerve : A Case Report

이하선의 심엽에 위치하며 안면신경의 볼가지를 침범한 타액관 암종 1예

  • Kim, Jung Min (Department of Otolaryngology-Head and Neck Surgery, VHS Medical Center) ;
  • Kwak, Seul Ki (Department of Otolaryngology-Head and Neck Surgery, VHS Medical Center) ;
  • Kim, Seung Woo (Department of Otolaryngology-Head and Neck Surgery, VHS Medical Center)
  • 김정민 (중앙보훈병원 이비인후과) ;
  • 곽슬기 (중앙보훈병원 이비인후과) ;
  • 김승우 (중앙보훈병원 이비인후과)
  • Received : 2012.09.27
  • Accepted : 2012.10.30
  • Published : 2012.11.30

Abstract

Salivary duct carcinoma(SDC) is a highly malignant tumor of the salivary gland. The tumor is clinically characterized by a rapid onset and progression, the neoplasm is often associated with pain and facial paralysis. The nodal recurrence rate is high, and distant metastasis is common. SDC resembles high-grade breast ductal carcinoma. Curative surgical resection and postoperative radiation were the mainstay of the treatment. If facial paralysis is present, a radical parotidectomy is mandatory. Regardless of the primary location of SDC, ipsilateral functional neck dissection is indicated, because regional lymphatic spread has to be expected in the majority of patients already at time of diagnosis. If there is minor gland involvement, a bilateral neck dissection should be performed, because lymphatic drainage may occur to the contralateral side. The survival of SDC patient is poor, with most dying within three years. We experienced a unique case of SDC in parotid deep lobe. We report the clinicopathologic features of this tumor with a review of literature.

Keywords

References

  1. Kleinsasser O, Klein H, Hubner G. Sailvary duct carcinoma: a group of salivary gland tumors analogue to mammary duct carcinoma. Arch KIin Exp Ohren Nasen Kehlkopfheid. 1968;192:100-115. https://doi.org/10.1007/BF00301495
  2. Jaehne M, Roeser L, Jaekel T, Schepers JD, Albert N, Loning T. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer. 2005;103:2526-2533. https://doi.org/10.1002/cncr.21116
  3. Seifert G, Batsakis JG, Brocheriou C. World Health Organization International Classification of Tumours: Histological Typing of Salivary Gland Tumours, 2nd edn. Berlin: Springer-Verlag;1991.
  4. Zbaren P, Zbaren S, Caversaccio MD, Stuffer E. Carcinoma expleomorphic adenoma: Diagnostic difficulty and outcome. Otolaryngol Head Neck Surg. 2008;138:601-606. https://doi.org/10.1016/j.otohns.2008.01.013
  5. HS Jeong, HS Lee, HJ Lee, YH Koh, CH Baek, YI Son. Salivary Duct Carcinoma: A Clinicopathologic Analysis and Treatment Outcome. Korean J Otolaryngol. 2003;46:318-323.
  6. Wee DTH, Thomas AA, Bradley PJ. Salivary duct carcinoma: what is already known, and can we improve survival? The Journal of Laryngology & Otology. 2012;126:S2-S7. https://doi.org/10.1017/S0022215112000412
  7. Garcia-Bonafe M, Catala I, Tarragona J, Tallada N. Cytologic diagnosis of salivary duct carcinoma: A review of seven cases. Diagn Cytopathol. 1998;19:120-123. https://doi.org/10.1002/(SICI)1097-0339(199808)19:2<120::AID-DC11>3.0.CO;2-H
  8. Etges A, Pinto DS Jr, Kowalski LP, Soares FA, Araujo VC. Salivary duct carcinoma: Immunohistochemical profile of and aggressive salivary gland tumour. J Clinpathol. 2003;56;914-918.